Market Capitalization (Millions $) |
116 |
Shares
Outstanding (Millions) |
12 |
Employees |
- |
Revenues (TTM) (Millions $) |
- |
Net Income (TTM) (Millions $) |
2 |
Cash Flow (TTM) (Millions $) |
0 |
Capital Exp. (TTM) (Millions $) |
0 |
Eucrates Biomedical Acquisition Corp
Eucrates Biomedical Acquisition Corp is a special purpose acquisition company (SPAC) focused on the healthcare and life sciences sectors. It was established as a blank-check company with the purpose of merging or acquiring an existing company in the biotechnology, pharmaceutical, medical device, or healthcare services industries. The company aims to identify attractive investment opportunities in these sectors and provide capital and expertise to help them grow and succeed. Eucrates Biomedical Acquisition Corp is likely led by experienced professionals in the healthcare industry who evaluate potential targets and negotiate business combinations.
Company Address: 250 West 55th Street, Suite 13D New York 10019 NY
Company Phone Number: 710-5220 Stock Exchange / Ticker: NASDAQ EUCR
EUCR is expected to report next financial results on April 12, 2024. |
|
|